Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor –kappa B activation: A possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smoking-Reference-Cited by-同舟云学术

Crosstalk between tumor necrosis factor-alpha signaling and aryl hydrocarbon receptor signaling in nuclear factor –kappa B activation: A possible molecular mechanism underlying the reduced efficacy of TNF-inhibitors in rheumatoid arthritis by smoking

Published:2019-03 Issue: Volume:98 Page:95-102
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Nii Takuro,Kuzuya Kentaro^ORCID,Kabata Daijiro,Matsui Toshihiro,Murata Atsuko,Ohya Takeshi,Matsuoka Hidetoshi,Shimizu Takashi,Oguro Eri,Okita Yasutaka,Udagawa Chikako,Yoshimura Maiko,Kudo-Tanaka Eriko,Teshigawara Satoru,Harada Yoshinori,Yoshida Yuji,Isoda Kentaro,Tsuji So-Ichiro,Ohshima Shiro,Hashimoto Jun,Shintani Ayumi,Takehana Yasuo,Tohma Shigeto,Saeki Yukihiko

Funder

Japan Society for the Promotion of Science

Japan National Hospital Organization

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference52 articles.

1. Rheumatoid arthritis;Klareskog;Lancet,2009

2. NF-κB and its relevance to arthritis and inflammation;Simmonds;Rheumatology,2008

3. Rheumatoid arthritis: from autoimmunity to synovitis and joint destruction;Boissier;J. Autoimmun.,2012

4. Pathogenetic insights from the treatment of rheumatoid arthritis;McInnes;Lancet,2017

5. Biologics-based therapy for the treatment of rheumatoid arthritis;Scott;Clin. Pharmacol. Ther.,2012

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of smoking on clinical treatment outcomes amongst patients with chronic inflammatory diseases initiating biologics: secondary analyses of the prospective BELIEVE cohort study;Scandinavian Journal of Immunology;2024-07-07

2. A Review of Difficult-to-Treat Rheumatoid Arthritis: Definition, Clinical Presentation, and Management;Current Rheumatology Reports;2023-09-30

3. Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis;Rheumatology;2023-09-19

4. The aryl hydrocarbon receptor in immune regulation and autoimmune pathogenesis;Journal of Autoimmunity;2023-07

5. Genomic repertoires linked with pathogenic potency of arthritogenicPrevotella copriisolated from the gut of patients with rheumatoid arthritis;Annals of the Rheumatic Diseases;2023-01-10